Each chemokine was tested for its ability to chemoattract L1.2 mouse B cell lymphoma cells expressing the cognate mouse receptors Ccr6, Ccr7, and Ccr1, respectively, in the presence of increasing doses of DOPS or DOPC liposomes. The gene discussed is CCR7; the disease is B-cell non-Hodgkin lymphoma.